Why the study?
Does percutaneous transluminal renal angioplasty improve standing blood pressure in a patient with orthostatic hypertension due to renal fibromuscular dysplasia and nephroptosis?
Does percutaneous transluminal renal angioplasty improve standing blood pressure in a patient with orthostatic hypertension due to renal fibromuscular dysplasia and nephroptosis?
Percutaneous transluminal renal angioplasty can effectively treat orthostatic hypertension caused by renal fibromuscular dysplasia and nephroptosis.
Answers are grounded in this paper and cite their sources.
May support angioplasty in orthostatic hypertension from fibromuscular dysplasia with nephroptosis; leaves open confirmation in prospective studies.
A 42-year-old woman presented with orthostatic hypertension. Increased plasma renin activity was noted and blood pressure rose gradually with standing. Selective renal arteriography indicated narrowing of the distal portion of the right renal artery and poststenotic dilatation and signs of arterial stenosis due to fibromuscular dysplasia. Greater arterial narrowing resulted from tortion due to nephroptosis brought about by excessive renin secretion. Thus, both renal arterial stenosis and nephroptosis were considered responsible for the present orthostatic hypertension. Percutaneous transluminal renal angioplasty was found very effective for normalizing standing blood pressure and renal blood flow.
No takes yet. Share an insight, caveat, or question.
Tsukamoto et al. (1988) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: